Literature DB >> 1254962

Gentic control of the immune response to the Ea-2 alloantigen system of the mouse. I. The humoral antibody response.

J H Stimpfling, A E Reichert, S Blanchard.   

Abstract

The immunization of selected congenic strains and hybrids against the Ea-2.1 cellular alloantigen of the mouse demonstrated that the hammagglutinating antibody response to Ea-2.1 is regulated by a gene or genes associated with the H-2 gene complex. H-2r and H-2b are, respectively, responder and non-responder haplotypes.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1254962

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 2.  Lessons learned from mouse models of hemolytic transfusion reactions.

Authors:  Eldad A Hod; James C Zimring; Steven L Spitalnik
Journal:  Curr Opin Hematol       Date:  2008-11       Impact factor: 3.284

3.  Immune response inversion after hyperimmunisation. Possible mechanism in the pathogenesis of HLA-linked diseases.

Authors:  C R Young; A Ebringer; J R Archer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

4.  H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. I. Donor H-2D region control of H-7.1-immunogenicity and lack of restriction in vivo.

Authors:  P J Wettstein; G Haughton; J A Frelinger
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

5.  Sickle Cell Trait Increases Red Blood Cell Storage Hemolysis and Post-Transfusion Clearance in Mice.

Authors:  David O Osei-Hwedieh; Tamir Kanias; Claudette St Croix; Morgan Jessup; Zeyu Xiong; Derek Sinchar; Jonathan Franks; Qinzi Xu; Enrico M Novelli; Jonas T Sertorio; Karin Potoka; Robert J Binder; Swati Basu; Andrea M Belanger; Daniel B Kim-Shapiro; Darrell Triulzi; Janet S Lee; Mark T Gladwin
Journal:  EBioMedicine       Date:  2016-08-04       Impact factor: 8.143
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.